Expression of recombinant puroindolines for the treatment of staphylococcal skin infections (acne vulgaris)

33Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Puroindolines are antimicrobial peptides that occur in wheat seed, and are characterized by broad antimicrobial activity. We describe the heterologous expression of puroindoline A and B in the Origami strain of Escherichia coli. The recombinant puroindolines showed the same antimicrobial activity on Staphylococcus epidermidis as compared to the native peptides (MIC90 = 30 μg ml-1). The bactericidal activity was 125 μg ml-1 for recombinant puroindoline A and 42 μg ml-1 for recombinant puroindoline B. Neither protein shows in vitro haemolytic activity or toxicity towards the murine macrophage cell line J774, but they are able to kill intracellular staphylococci. Our preliminary results suggest that recombinant puroindolines deserve further attention as alternatives to the conventional antibiotics in the control of S. epidermidis skin infections. © 2006 Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Capparelli, R., Ventimiglia, I., Palumbo, D., Nicodemo, D., Salvatore, P., Amoroso, M. G., & Iannaccone, M. (2007). Expression of recombinant puroindolines for the treatment of staphylococcal skin infections (acne vulgaris). Journal of Biotechnology, 128(3), 606–614. https://doi.org/10.1016/j.jbiotec.2006.11.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free